个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Changes in the prevalence of polycystic ovary syndrome in China over the past decade.

| 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE ◇ SSCI

作者：
Yang Rui[1,2,3,4] * ; Li Qin[1,2,3,4] * ; Zhou Zehong[5,6] ; Qian Weiping[7] ; Zhang Jian[8] ; Wu Ze[9] ; Jin Lei[10] ; Wu Xueqing[11] ; Zhang Cuilian[12] ; Zheng Beihong[13] ; Tan Jichun[14] ; Hao Guimin[15] ; Li Shangwei[16] ; Tian Tian[1,2,3,4] ; Hao Yongxiu[1,2,3,4] ; Zheng Danni[1,2,3,4] ; Wang Yuanyuan[1,2,3,4] ; Norman Robert J[17] ; Li Rong[1,2,3,4] ; Liu Ping[1,2,3,4] ; Qiao Jie[1,2,3,4] ;
机构： [1]Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. [2]National Clinical Research Center for Obstetrics and Gynecology, Beijing 100191, China. [3]Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing 100191, China. [4]Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China. [5]Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China. [6]Department of Obstetrics and Gynecology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China. [7]Department of Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen 518036, China. [8]Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, School of Medicine, Shanghai 200240, China. [9]Department of Reproductive Medicine, The First People's Hospital of Yunnan Province, Kunming 650021, China. [10]Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. [11]Reproductive Medicine Center, Children's Hospital of Shanxi and Women Health Center of Shanxi, Affiliated Hospital of Shanxi Medical University, Taiyuan 030000, China. [12]Reproductive Medical Center, Henan Provincial People's Hospital, Zhengzhou 450003, China. [13]Reproductive Medicine Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &amp [14] Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350001, China. [14]Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110022, China. [15]Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China. [16]Division of Reproductive Medical Center, West China Second University Hospital of Sichuan University, Chengdu 610041, China. [17]Discipline of Obstetrics/Gynecology, Robinson Research Institute, The University of Adelaide, Adelaide, SA 5005, Australia.
出处：
DOI： 10.1016/j.lanwpc.2022.100494

关键词： Polycystic ovary syndrome Prevalence Trend Ultrasound

摘要：
Polycystic ovary syndrome (PCOS) has become a major international public health concern. However, because of controversy about the diagnostic criteria and patient selection, estimates of its absolute prevalence and change with time vary greatly.We conducted two consecutive nationwide epidemiological surveys of the prevalence of PCOS in representative samples of reproductive-aged women in China in 2010 and 2020. Face-to-face interviews were performed by trained interviewers in each survey. All participants completed a questionnaire and underwent a physical examination, blood sampling, and transvaginal pelvic ultrasound. We assessed hyperandrogenism (H), chronic anovulation (O), and polycystic ovaries (P) to classify the presence of PCOS using the Rotterdam criteria. The prevalence of PCOS among reproductive-aged women was estimated after consideration of differential probabilities of selection and population distribution. We conducted a logistic regression analysis by using the probability of PCOS as a function of the survey year to acquire the trend information across the years.28,739 respondents completed the survey, including 15,924 in the previously published 2010 survey and 12,815 in the new 2020 survey. In 2020, 826 participants could be diagnosed as having PCOS, with a weighted prevalence of 7.8% (95%CI: 7.0%, 9.0%) among women aged 20-49 years, leading to an estimate of 24.0 million women of reproductive age affected by this condition in China as a whole. The estimated prevalence in 2020 was higher than that of a decade ago despite identical research methods suggesting a two-thirds increase over the study period. Women with PCOS in 2020 also appeared to have a more severe phenotype overall than those of a decade ago, possibly reflecting a significantly higher prevalence of obesity, hyperandrogenism, and infertility.The prevalence of PCOS in Chinese women has increased significantly over the past 10 years. PCOS is a significant public health problem in women of reproductive age in China and national policy and guidelines should be re-examined in the light of the current data.National Key R&D Program of China and the National Natural Science Foundation of China.© 2022 The Authors.

语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务 2 区 公共卫生、环境卫生与职业卫生
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 卫生保健与服务 1 区 公共卫生、环境卫生与职业卫生
JCR分区：
出版当年[2021]版：
Q1 HEALTH CARE SCIENCES & SERVICES Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2023]版：
Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Q1 HEALTH CARE SCIENCES & SERVICES

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. [2]National Clinical Research Center for Obstetrics and Gynecology, Beijing 100191, China. [3]Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing 100191, China. [4]Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China.
共同第一作者：
通讯作者：
通讯机构： [1]Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. [2]National Clinical Research Center for Obstetrics and Gynecology, Beijing 100191, China. [3]Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing 100191, China. [4]Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China.
推荐引用方式(GB/T 7714)：
Yang Rui,Li Qin,Zhou Zehong,et al.Changes in the prevalence of polycystic ovary syndrome in China over the past decade.[J].LANCET REGIONAL HEALTH-WESTERN PACIFIC.2022,25:doi:10.1016/j.lanwpc.2022.100494.
APA：
Yang Rui,Li Qin,Zhou Zehong,Qian Weiping,Zhang Jian...&Qiao Jie.(2022).Changes in the prevalence of polycystic ovary syndrome in China over the past decade..LANCET REGIONAL HEALTH-WESTERN PACIFIC,25,
MLA：
Yang Rui,et al."Changes in the prevalence of polycystic ovary syndrome in China over the past decade.".LANCET REGIONAL HEALTH-WESTERN PACIFIC 25.(2022)

相关文献

[1]Coagulation parameters predictive of polycystic ovary syndrome [2]Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome [3]Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome [4]MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats. [5]The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome [6]Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment [7]Association of IL-17A gene polymorphism rs2275913 with the polycystic ovary syndrome in Yunnan Province, China. [8]Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China [9]Endometrial preparation protocol of the frozen-thawed embryo transfer in patients with polycystic ovary syndrome [10][Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].

资源点击量：82490 今日访问量：0 总访问量：681 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西山区金碧路157号